Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LHCG
451
DELISTED
LHC Group LLC
LHCG
| $35.7M | 0.05% |
220,969
+211,100
| +2,139% | +$34.9M |
|
452
Pan American Silver
PAAS
$19.9B
| $35.7M | 0.05% |
2,183,204
+55,800
| +3% | +$893K |
|
|
CFLT
453
DELISTED
Confluent
CFLT
| $35.6M | 0.05% |
1,599,941
+903,141
| +130% | +$20.9M |
|
|
GTY
454
Getty Realty Corp
GTY
$2.06B
| $35.6M | 0.05% |
1,050,312
-67,800
| -6% | -$2.14M |
|
455
monday.com
MNDY
$3.99B
| $35.5M | 0.05% |
291,300
-34,500
| -11% | -$3.59M |
|
|
COUP
456
DELISTED
Coupa Software Incorporated
COUP
| $35.5M | 0.05% |
447,900
-519,100
| -54% | -$31.1M |
|
457
Alliant Energy
LNT
$18.2B
| $35.4M | 0.05% |
641,950
-165,501
| -20% | -$8.84M |
|
458
CRA International
CRAI
$1.08B
| $35.3M | 0.05% |
288,375
-5,069
| -2% | -$558K |
|
459
Gen Digital
GEN
$17.7B
| $35.3M | 0.05% |
1,646,400
+394,400
| +32% | +$8.71M |
|
460
Qualys
QLYS
$6.78B
| $35M | 0.05% |
311,700
+79,000
| +34% | +$9.87M |
|
461
Ennis
EBF
$559M
| $35M | 0.05% |
1,577,849
-191,409
| -11% | -$4.25M |
|
462
Illinois Tool Works
ITW
$82.8B
| $34.8M | 0.05% |
+157,900
| New | +$33.6M |
|
463
Bio-Techne
TECH
$11.3B
| $34.7M | 0.05% |
418,400
-665,376
| -61% | -$52.8M |
|
|
TWNK
464
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $34.7M | 0.05% |
1,544,810
-47,100
| -3% | -$1.19M |
|
465
QuidelOrtho
QDEL
$1.05B
| $34.5M | 0.05% |
402,712
+24,600
| +7% | +$2.08M |
|
466
AB InBev
BUD
$158B
| $34.5M | 0.05% |
574,500
+114,900
| +25% | +$6.17M |
|
467
HEICO Corp Class A
HEI.A
$37.8B
| $34.5M | 0.05% |
287,484
+91,889
| +47% | +$11.2M |
|
468
Cognizant
CTSH
$26.8B
| $34.4M | 0.05% |
+602,235
| New | +$35.3M |
|
469
TechnipFMC
FTI
$30.1B
| $34.4M | 0.05% |
2,820,100
+1,762,000
| +167% | +$19.7M |
|
470
Royalty Pharma
RPRX
$26B
| $34.3M | 0.05% |
+869,000
| New | +$36.3M |
|
471
Labcorp
LH
$26.2B
| $34.2M | 0.05% |
169,019
-173,784
| -51% | -$34M |
|
472
Universal Display
OLED
$4.19B
| $34.2M | 0.05% |
316,339
-169,300
| -35% | -$17.8M |
|
473
Extreme Networks
EXTR
$3.17B
| $34.2M | 0.05% |
1,865,516
-118,100
| -6% | -$2.07M |
|
474
Lennox International
LII
$14.4B
| $34.1M | 0.05% |
142,600
+22,500
| +19% | +$5.51M |
|
475
Buckle
BKE
$2.3B
| $33.9M | 0.05% |
746,602
-86,350
| -10% | -$3.49M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.